Regeneron (REGN) Reports REGN5678 Shows Encouraging Anti-tumor Activity When Combined with PD-1 Inhibitor Libtayo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Regeneron (REGN) Reports REGN5678 Shows Encouraging Anti-tumor Activity When Combined with PD-1 Inhibitor Libtayo
Regeneron (NASDAQ: REGN) Delayed: 784.85 -4.6 (0.58%)
Previous Close $789.45    52 Week High $592.36 
Open $787.34    52 Week Low $325.35 
Day High $794.73    P/E 206.00 
Day Low $779.65    EPS $3.81 
Volume 2,473,425